Extramedullary T-lymphoblastic Crisis in a Myelodysplastic/Myeloproliferative Neoplasm with a t(12;22)/ MN1::ETV6 Translocation.
Ana Carolina FreitasTiago MaiaJoana DesterroFrancesca PierdomenicoAlbertina NunesIsabelina FerreiraJosé CabeçadasMaria Gomes da SilvaPublished in: Hematology reports (2023)
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are not a single disease, but rather a heterogenous group of entities which are increasingly subclassified according to recurrent genetic abnormalities. Chromosomal translocations involving meningioma 1 ( MN1 ) and ETS variant 6 ( ETV6 ) genes are extremely rare, but recurrent in myeloid neoplasms. We describe the case of a patient with a myelodysplastic/myeloproliferative neoplasm with neutrophilia, who developed an extramedullary T-lymphoblastic crisis with the t(12;22)(p13;q12) translocation as the only cytogenetic abnormality. This case shares several clinical and molecular features with myeloid/lymphoid neoplasms with eosinophilia. The treatment of this patient was challenging, as the disease proved to be highly refractory to chemotherapy, with allogenic stem cell transplantation as the only curative option. This clinical presentation has not been reported in association with these genetic alterations and supports the concept of a hematopoietic neoplasm originating in an early uncommitted precursor cell. Additionally, it stresses the importance of molecular characterization in the classification and prognostic stratification of these entities.
Keyphrases
- bone marrow
- acute myeloid leukemia
- stem cell transplantation
- genome wide
- low grade
- public health
- acute lymphoblastic leukemia
- high dose
- copy number
- case report
- mesenchymal stem cells
- single cell
- machine learning
- dendritic cells
- transcription factor
- deep learning
- room temperature
- immune response
- dna methylation
- radiation therapy
- prognostic factors
- low dose
- transition metal
- replacement therapy
- single molecule